Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibody

Details for Product No. ABIN363493
Target
Binding Specificity
N-Term
16
7
7
4
2
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Mouse
94
33
23
Host
Rabbit
68
22
7
2
Clonality
Polyclonal
Conjugate
Un-conjugated
11
10
10
5
4
4
3
2
2
2
2
2
2
2
2
2
2
Application
Western Blotting (WB)
50
41
35
26
9
4
4
4
2
2
1
Options
Immunogen Synthetic peptide made to an N-terminal portion of the murine cripto protein sequence
Specificity Reacts with mouse ~18 kDa (core form) and ~36 kDa (glycosylated/ post-transcriptionally modified form) TDGF1 protein
Cross-Reactivity (Details) May cross reacts with human protein. (78 % sequence homology).
Purification Antigen affinity purified
Target
Alternative Name Teratocarcinoma-Derived Growth Factor 1 (TDGF1 Antibody Abstract)
Pathways EGFR Signaling Pathway
Application Notes

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- WB : 1/500 to 1/2 000

Restrictions For Research Use only
Format Liquid
Buffer Tris-glycine, NaCl 150 mM buffer, Sodium azide
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store at 4°C. Do not freeze.
Images
Image no. 1 for anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibody (ABIN363493) anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibody (Image 1)
Image no. 2 for anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibody (ABIN363493) anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibody (Image 2)
Image no. 3 for anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibody (ABIN363493) anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibody (Image 3)
Image no. 4 for anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibody (ABIN363493) anti-Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (N-Term) antibody (Image 4)